These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 28730728)
1. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice. Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice. O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR PLoS One; 2018; 13(8):e0202350. PubMed ID: 30157220 [TBL] [Abstract][Full Text] [Related]
3. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice. Irwin N; Hunter K; Montgomery IA; Flatt PR Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064 [TBL] [Abstract][Full Text] [Related]
4. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice. O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054 [TBL] [Abstract][Full Text] [Related]
5. Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions. O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR Peptides; 2018 Feb; 100():219-228. PubMed ID: 29412822 [TBL] [Abstract][Full Text] [Related]
6. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759 [TBL] [Abstract][Full Text] [Related]
7. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates. Elvert R; Herling AW; Bossart M; Weiss T; Zhang B; Wenski P; Wandschneider J; Kleutsch S; Butty U; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Lorenz M; Keil S; Larsen PJ Diabetes Obes Metab; 2018 Aug; 20(8):1836-1851. PubMed ID: 29938884 [TBL] [Abstract][Full Text] [Related]
8. A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice. Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N Peptides; 2018 Feb; 100():202-211. PubMed ID: 29412820 [TBL] [Abstract][Full Text] [Related]
9. Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db/db mice. O'Harte FPM; Parthsarathy V; Flatt PR Mol Cell Endocrinol; 2020 Mar; 504():110695. PubMed ID: 31904406 [TBL] [Abstract][Full Text] [Related]
10. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln. Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814 [TBL] [Abstract][Full Text] [Related]
11. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice. Irwin N; Pathak V; Flatt PR Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113 [TBL] [Abstract][Full Text] [Related]
12. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice. Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687 [TBL] [Abstract][Full Text] [Related]
13. Stable oxyntomodulin analogues exert positive effects on hippocampal neurogenesis and gene expression as well as improving glucose homeostasis in high fat fed mice. Pathak NM; Pathak V; Lynch AM; Irwin N; Gault VA; Flatt PR Mol Cell Endocrinol; 2015 Sep; 412():95-103. PubMed ID: 26048772 [TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes. Vasu S; Ojo OO; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YHA Amino Acids; 2017 Oct; 49(10):1705-1717. PubMed ID: 28836148 [TBL] [Abstract][Full Text] [Related]
16. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice. Tomas E; Wood JA; Stanojevic V; Habener JF Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160 [TBL] [Abstract][Full Text] [Related]
17. A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents. Nørregaard PK; Deryabina MA; Tofteng Shelton P; Fog JU; Daugaard JR; Eriksson PO; Larsen LF; Jessen L Diabetes Obes Metab; 2018 Jan; 20(1):60-68. PubMed ID: 28598027 [TBL] [Abstract][Full Text] [Related]
18. [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice. Srinivasan DK; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH Acta Diabetol; 2016 Apr; 53(2):303-15. PubMed ID: 26138324 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of (pGlu-Gln)-CCK-8 on energy intake and metabolism in high fat fed mice are associated with alterations of hypothalamic gene expression. Montgomery IA; Irwin N; Flatt PR Horm Metab Res; 2013 Jun; 45(6):471-3. PubMed ID: 23315994 [TBL] [Abstract][Full Text] [Related]
20. Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice. Pathak NM; Millar PJB; Pathak V; Flatt PR; Gault VA Mol Cell Endocrinol; 2018 Jan; 460():200-208. PubMed ID: 28754350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]